HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yalun Li Selected Research

Liver Neoplasms (Liver Cancer)

11/2021Tumor-targeted hyaluronic acid-mPEG modified nanostructured lipid carriers for cantharidin delivery: An in vivo and in vitro study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yalun Li Research Topics

Disease

21Neoplasms (Cancer)
12/2021 - 09/2014
13Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2018
11Breast Neoplasms (Breast Cancer)
10/2022 - 01/2019
10Neoplasm Metastasis (Metastasis)
12/2021 - 09/2014
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 09/2014
5Carcinogenesis
01/2022 - 01/2020
5Lung Neoplasms (Lung Cancer)
08/2021 - 01/2014
3Adenocarcinoma of Lung
01/2022 - 01/2019
3Pain (Aches)
01/2020 - 07/2009
3Carcinoma (Carcinomatosis)
03/2019 - 04/2015
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2021 - 01/2017
2Lymphatic Metastasis
01/2021 - 04/2015
2Infections
01/2020 - 10/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2017 - 01/2017
2Adenocarcinoma
03/2017 - 01/2017
2Infertility (Sterility)
01/2012 - 07/2009
2Endometriosis
01/2012 - 07/2009
1Acquired Immunodeficiency Syndrome (AIDS)
03/2022
1Liver Neoplasms (Liver Cancer)
11/2021
1Hypoxia (Hypoxemia)
01/2021
1COVID-19
01/2021
1Anemia
01/2020
1Osteomalacia
01/2020
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
01/2020
1Abdominal Aortic Aneurysm
01/2020
1Muscle Weakness
01/2020
1Pleural Tuberculosis
07/2019
1Triple Negative Breast Neoplasms
01/2019
1Intestinal Obstruction (Obstruction, Intestinal)
10/2018
1Sarcopenia
10/2018

Drug/Important Bio-Agent (IBA)

6Long Noncoding RNAIBA
01/2022 - 01/2019
6Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2017
5Messenger RNA (mRNA)IBA
10/2022 - 01/2019
5MicroRNAs (MicroRNA)IBA
01/2021 - 01/2020
4human ERBB2 proteinIBA
01/2021 - 04/2015
3Proteins (Proteins, Gene)FDA Link
08/2022 - 11/2020
36-methyladenineIBA
01/2022 - 01/2020
3CrizotinibIBA
01/2022 - 01/2019
3Estrogen ReceptorsIBA
01/2019 - 04/2015
3Progesterone Receptors (Progesterone Receptor)IBA
01/2019 - 04/2015
2N-methyladenosineIBA
01/2022 - 11/2021
2Gefitinib (Iressa)FDA Link
01/2022 - 01/2019
2Immune Checkpoint InhibitorsIBA
12/2021 - 08/2021
2LipidsIBA
11/2021 - 04/2015
2Tyrosine Kinase InhibitorsIBA
10/2020 - 01/2020
2Biological ProductsIBA
01/2019 - 04/2015
2Pentoxifylline (Trental)FDA LinkGeneric
01/2012 - 07/2009
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2022
1Paclitaxel (Taxol)FDA LinkGeneric
10/2022
1Phenobarbital (Luminal)FDA Link
08/2022
1Oxygen (Dioxygen)IBA
03/2022
1ElectrolytesIBA
03/2022
1SaltsIBA
03/2022
1Interleukin-11 (Interleukin 11)IBA
12/2021
1B7-H1 AntigenIBA
12/2021
1Hyaluronic Acid (Hyaluronan)IBA
11/2021
1Cantharidin (Cantharides)IBA
11/2021
1monomethoxypolyethylene glycol (MPEG)IBA
11/2021
1Therapeutic UsesIBA
08/2021
1alectinibIBA
01/2021
1Transforming Growth Factor beta (TGF-beta)IBA
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
10/2020
1osimertinibIBA
10/2020
1Apoptotic Protease-Activating Factor 1IBA
09/2020
1Internal Ribosome Entry SitesIBA
09/2020
1Circular RNAIBA
03/2020
1Small Nucleolar RibonucleoproteinsIBA
01/2020
1insulin receptor-related receptor (IRR)IBA
01/2020
1pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)IBA
01/2020
1Calcibiotic Root Canal SealerIBA
01/2020
1Cell-Free Nucleic AcidsIBA
01/2020
1Competitive Endogenous RNAIBA
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1MelatoninIBA
01/2020
1NicotineFDA Link
01/2020
1Small Nucleolar RNA (snoRNA)IBA
01/2020
1AcidsIBA
07/2019
1Indicators and Reagents (Reagents)IBA
04/2019
1Annexin A3IBA
03/2019
1Trastuzumab (Herceptin)FDA Link
01/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2019
1Pharmaceutical PreparationsIBA
01/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2018
1Urea (Carbamide)FDA LinkGeneric
03/2017
1Serum AlbuminIBA
03/2017
1Phosphopyruvate Hydratase (Enolase)IBA
01/2017
1Keratin-19 (Keratin 19)IBA
01/2017
1Carcinoembryonic AntigenIBA
01/2017
1Peptides (Polypeptides)IBA
11/2016
1arginyllysineIBA
11/2016
1NeuropilinsIBA
11/2016
1Neuropilin-1IBA
11/2016
1LyP-1 peptideIBA
11/2016

Therapy/Procedure

7Therapeutics
11/2021 - 07/2009
3Immunotherapy
12/2021 - 01/2021
2Drug Therapy (Chemotherapy)
11/2021 - 01/2019
1Neoadjuvant Therapy
03/2019
1Length of Stay
10/2018